Form 4: Syra Health Corp Director Acquires Stock Options

A Syra Health Corp director, Avutu Reddy, acquired 12,136 stock options on January 7, 2025, under the company's 2022 Omnibus Equity Incentive Plan.

Summary

• Avutu Reddy, a director at Syra Health Corp, acquired 12,136 stock options on January 7, 2025.
• These options were granted under the company's 2022 Omnibus Equity Incentive Plan.
• 25% of the options vested immediately, and the remaining options will vest in 12 equal monthly installments.
• The exercise price of the options is $0.7386 per share.
• The options expire on January 7, 2035.
• Following this transaction, Mr. Reddy directly owns 27,578 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options to a director, which is generally a positive sign of alignment between management and shareholders. It is not a major event, but it is a positive indicator.

Positives

• The acquisition of stock options by a director demonstrates confidence in the company's future performance.
• The vesting schedule of the options aligns the director's interests with the long-term success of the company.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation and incentive programs.
• The vesting schedule of 25% immediately and the remainder over 12 months is a fairly standard approach to align director interests with company performance.
• The 10-year expiration period for the options is also typical in the industry.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, potentially leading to better decision-making.
• The vesting schedule encourages the director to focus on the long-term success of the company.

Key Dates

Keywords

stock options, insider trading, equity incentive plan, beneficial ownership, Syra Health Corp, director, Avutu Reddy